{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:01:37Z","timestamp":1791669697275,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022MH180"],"award-info":[{"award-number":["ZR2022MH180"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2020-54-18"],"award-info":[{"award-number":["2020-54-18"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2020-54-20"],"award-info":[{"award-number":["2020-54-20"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115107","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T06:58:15Z","timestamp":1688713095000},"page":"115107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A mechanistic updated overview on Cepharanthine as potential anticancer agent"],"prefix":"10.1016","volume":"165","author":[{"given":"YingZheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HuaXin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WeiDong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoYan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2246-2308","authenticated-orcid":false,"given":"YaNan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2023.115107_bib1","first-page":"381","article-title":"Barnholtz-Sloan JS. Brain and other central nervous system tumor statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2023.115107_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.769751","article-title":"Case Report: diffuse large B cell lymphoma after cardiac transplantation due to anthracycline-induced dilated cardiomyopathy in pediatric acute lymphoblastic leukemia","volume":"13","author":"Xin","year":"2022","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2023.115107_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12288-021-01444-7","article-title":"Primary central nervous system lymphoma: long-term treatment outcomes and cost-analysis from a retrospective study of high-dose methotrexate based chemoimmunotherapy and reduced dose radiation therapy approach","volume":"38","author":"Vs","year":"2022","journal-title":"Indian J. Hematol. Blood Transfus."},{"issue":"4","key":"10.1016\/j.biopha.2023.115107_bib4","doi-asserted-by":"crossref","first-page":"10111","DOI":"10.1080\/21655979.2022.2063664","article-title":"Astragaloside IV exhibits anti-tumor function in gastric cancer via targeting circRNA dihydrolipoamide S-succinyltransferase (circDLST)\/miR-489-3p\/ eukaryotic translation initiation factor 4A1(EIF4A1) pathway","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.biopha.2023.115107_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.867318","article-title":"Research advances on matrine","volume":"10","author":"Sun","year":"2022","journal-title":"Front Chem."},{"issue":"05","key":"10.1016\/j.biopha.2023.115107_bib6","first-page":"591","article-title":"Determination of cepharanthine in plants of Stephania Lour. from various habitats by HPLC","volume":"31","author":"Xiao","year":"2016","journal-title":"Drugs Clin."},{"issue":"5","key":"10.1016\/j.biopha.2023.115107_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2023.115107_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/a-0706-7503","article-title":"Mechanism of cepharanthine cytotoxicity in human ovarian cancer cells","volume":"85","author":"Payon","year":"2019","journal-title":"Planta Med"},{"issue":"1","key":"10.1016\/j.biopha.2023.115107_bib9","first-page":"227","article-title":"Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1\/Cip1","volume":"39","author":"Rattanawong","year":"2018","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2023.115107_bib10","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.3892\/or.2015.4193","article-title":"Mechanisms and in vitro effects of cepharanthine hydrochloride: Classification analysis of the drug-induced differentially-expressed genes of human nasopharyngeal carcinoma cells","volume":"34","author":"Liu","year":"2015","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2023.115107_bib11","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1159\/000471234","article-title":"Cepharanthine induces autophagy, apoptosis and cell cycle arrest in breast cancer cells","volume":"41","author":"Gao","year":"2017","journal-title":"Cell Physiol. Biochem"},{"issue":"19","key":"10.1016\/j.biopha.2023.115107_bib12","first-page":"3607","article-title":"Study on the effect and mechanism of qianjin tensu intraperitoneal injection on ovarian cancer model rats","volume":"21","author":"Cai","year":"2021","journal-title":"Prog. Mod. Biomed."},{"issue":"15","key":"10.1016\/j.biopha.2023.115107_bib13","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.7150\/ijbs.64675","article-title":"Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis in vivo","volume":"17","author":"Feng","year":"2021","journal-title":"Int J. Biol. Sci."},{"issue":"03","key":"10.1016\/j.biopha.2023.115107_bib14","first-page":"403","article-title":"Influences of cepharanthine on the apoptosis of oral squamous cell carcinoma cells and the expressions of FOXL2 and Ki67","volume":"22","author":"Yu","year":"2019","journal-title":"China Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2023.115107_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.119132","article-title":"Cepharanthine, a novel selective ANO1 inhibitor with potential for lung adenocarcinoma therapy","volume":"1868","author":"Zhang","year":"2021","journal-title":"Biochim Biophys. Acta Mol. Cell Res"},{"issue":"02","key":"10.1016\/j.biopha.2023.115107_bib16","first-page":"183","article-title":"Effects of cepharanthine on proliferation and apoptosis of cervical cancer cells by regulating MAPK signaling pathway through MAT2B","volume":"15","author":"Ying","year":"2020","journal-title":"Chin. Med Biotechnol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115107_bib17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/nu10081021","article-title":"Anti-cancer natural products and their bioactive compounds inducing er stress-mediated apoptosis: a review","volume":"10","author":"Kim","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2023.115107_bib18","first-page":"46","article-title":"New progress in tumor cell redifferentiation and oxidative therapy","volume":"01","author":"Zho","year":"2000","journal-title":"China Cancer"},{"key":"10.1016\/j.biopha.2023.115107_bib19","doi-asserted-by":"crossref","unstructured":"Lau A.T., Wang Y., Chiu J.F. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic[J]. 2008, 104(2): 657\u2013667.","DOI":"10.1002\/jcb.21655"},{"issue":"5","key":"10.1016\/j.biopha.2023.115107_bib20","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.3892\/ol.2017.5945","article-title":"Cepharanthine exerts antitumor activity on choroidal melanoma by reactive oxygen species production and c-Jun N-terminal kinase activation","volume":"13","author":"Zhu","year":"2017","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.biopha.2023.115107_bib21","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jsps.2020.08.026","article-title":"Cepharanthine induces ROS stress in glioma and neuronal cells via modulation of VDAC permeability","volume":"28","author":"Cierluk","year":"2020","journal-title":"Saudi Pharm. J."},{"issue":"2","key":"10.1016\/j.biopha.2023.115107_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbrc.2015.02.131","article-title":"Cepharanthine induces apoptosis through reactive oxygen species and mitochondrial dysfunction in human non-small-cell lung cancer cells","volume":"460","author":"Hua","year":"2015","journal-title":"Biochem Biophys. Res Commun."},{"issue":"18","key":"10.1016\/j.biopha.2023.115107_bib23","first-page":"1837","article-title":"Research progress in the biological function of miRNA-31 and its relationship with tumor","volume":"19","author":"Wang","year":"2021","journal-title":"Oncol. Prog."},{"issue":"11","key":"10.1016\/j.biopha.2023.115107_bib24","first-page":"1987","article-title":"Cepharanthine promotes A549 cell apoptosis by regulating miR-150 and miR-182","volume":"33","author":"Hao","year":"2017","journal-title":"Chin. J. Pathophysiol."},{"issue":"09","key":"10.1016\/j.biopha.2023.115107_bib25","first-page":"1586","article-title":"Cepharanthine promotes apoptosis of RL-952 cells by regulating eIF4Erelated miR-215","volume":"34","author":"Li","year":"2018","journal-title":"Chin. J. Pathophysiol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115107_bib26","first-page":"1824","article-title":"Effect of cepharanthine on proliferation and apoptosis of colon cancer cells by miR-34a","volume":"15","author":"Zho","year":"2020","journal-title":"World J. Integr. Tradit. West. Med."},{"key":"10.1016\/j.biopha.2023.115107_bib27","series-title":"Study on the Effect and Mechanism of Cepharanthine on Pancreatic Cancer Cells","author":"Liang","year":"2021"},{"issue":"6","key":"10.1016\/j.biopha.2023.115107_bib28","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/ijc.24521","article-title":"Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway","volume":"125","author":"Takahashi-Makise","year":"2009","journal-title":"Int J. Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2023.115107_bib29","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.3390\/ijms19103280","article-title":"Cepharanthine enhances TRAIL-mediated apoptosis through STAMBPL1-mediated downregulation of survivin expression in renal carcinoma cells","volume":"19","author":"Shahriyar","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115107_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade","volume":"370","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2023.115107_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drup.2012.03.002","article-title":"Collateral sensitivity as a strategy against cancer multidrug resistance","volume":"15","author":"Pluchino","year":"2012","journal-title":"Drug Resist Updat"},{"issue":"5","key":"10.1016\/j.biopha.2023.115107_bib32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development","volume":"20","author":"Choi","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"20","key":"10.1016\/j.biopha.2023.115107_bib33","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2174\/092986708785132870","article-title":"Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development","volume":"15","author":"Zhou","year":"2008","journal-title":"Curr. Med Chem."},{"issue":"67","key":"10.1016\/j.biopha.2023.115107_bib34","doi-asserted-by":"crossref","first-page":"111144","DOI":"10.18632\/oncotarget.22676","article-title":"Cepharanthine hydrochloride reverses the mdr1 (p-glycoprotein)- mediated esophageal squamous cell carcinoma cell cisplatin resistance through jnk and p53 signals","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"issue":"05","key":"10.1016\/j.biopha.2023.115107_bib35","first-page":"39","article-title":"Reversal effect and mechanism of cepharanthines on the drug resistan of CNE2\/ADM cell line in human nasopharyngeal carcinoma","volume":"33","author":"Wang","year":"2017","journal-title":"Pharmacol. Clin. Chin. Mater. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.115107_bib36","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.3892\/or.2017.5879","article-title":"Cepharanthine hydrochloride reverses P-glycoprotein-mediated multidrug resistance in human ovarian carcinoma A2780\/Taxol cells by inhibiting the PI3K\/Akt signaling pathway","volume":"38","author":"Huang","year":"2017","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2023.115107_bib37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.bcp.2008.12.005","article-title":"Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance","volume":"77","author":"Zhou","year":"2009","journal-title":"Biochem Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115107_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41401-021-00715-3","article-title":"Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis","volume":"43","author":"Shen","year":"2022","journal-title":"Acta Pharm. Sin."},{"issue":"23","key":"10.1016\/j.biopha.2023.115107_bib39","first-page":"2154","article-title":"Molecular mechanism of cepharanthine synergistically acting with doxorubicin in reversing multidrug resistance of K562 \/ADR cells","volume":"40","author":"Jiang","year":"2018","journal-title":"J. Army Med. Univ."},{"key":"10.1016\/j.biopha.2023.115107_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fcimb.2019.00225","article-title":"Cepharanthine hydrochloride improves cisplatin chemotherapy and enhances immunity by regulating intestinal microbes in mice","volume":"9","author":"Zhou","year":"2019","journal-title":"Front Cell Infect. Microbiol"},{"issue":"2","key":"10.1016\/j.biopha.2023.115107_bib41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3892\/ijo.2012.1501","article-title":"The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma","volume":"41","author":"Harada","year":"2012","journal-title":"Int J. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115107_bib42","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrclinonc.2011.71","article-title":"Autophagy as a target for anticancer therapy","volume":"8","author":"Janku","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.biopha.2023.115107_bib43","first-page":"2352","article-title":"Cepharanthine inhibits autophagic degradation in breast cancer MDA-MB-231 cells","volume":"39","author":"Deng","year":"2017","journal-title":"J. Army Med. Univ."},{"issue":"22","key":"10.1016\/j.biopha.2023.115107_bib44","first-page":"2229","article-title":"Cepharanthine sensitizes triple-negative breast cancer cells to doxorubicin and inhibit cell proliferation","volume":"41","author":"Zhang","year":"2019","journal-title":"J. Army Med. Univ."},{"key":"10.1016\/j.biopha.2023.115107_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2017.10.001","article-title":"Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer","volume":"412","author":"Tang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2023.115107_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.601969","article-title":"Cepharanthine as a potential novel tumor-regional therapy in treating cutaneous melanoma: altering the expression of cathepsin B, tumor suppressor genes and autophagy-related proteins","volume":"8","author":"Liu","year":"2020","journal-title":"Front Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2023.115107_bib47","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1101\/gad.325514.119","article-title":"Role of tumor and host autophagy in cancer metabolism","volume":"33","author":"Poillet-Perez","year":"2019","journal-title":"Genes Dev."},{"issue":"05","key":"10.1016\/j.biopha.2023.115107_bib48","first-page":"940","article-title":"Cepharanthine induces autophagy via PI3K \/AKT \/mTOR signaling pathway in ovarian cancer SKOV3 cells","volume":"35","author":"Xiang","year":"2019","journal-title":"Chin. J. Pathophysiol."},{"issue":"05","key":"10.1016\/j.biopha.2023.115107_bib49","first-page":"744","article-title":"Cepharanthine reverses icotinib resistance in human non-small cell lung cancer cells by regulating p53 signaling-mediated autophagy","volume":"27","author":"Liu","year":"2022","journal-title":"J. Clin. Pulm. Med."},{"issue":"8","key":"10.1016\/j.biopha.2023.115107_bib50","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2174\/1871520621666210903163407","article-title":"Cepharanthine regulates autophagy via activating the p38 signaling pathway in lung adenocarcinoma cells","volume":"22","author":"Li","year":"2022","journal-title":"Anticancer Agents Med Chem."},{"issue":"4","key":"10.1016\/j.biopha.2023.115107_bib51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/14728222.2020.1737013","article-title":"Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC)","volume":"24","author":"Wang","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2023.115107_bib52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2017.09.009","article-title":"Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth","volume":"409","author":"Lyu","year":"2017","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.biopha.2023.115107_bib53","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrc1075","article-title":"Tumour-cell invasion and migration: diversity and escape mechanisms","volume":"3","author":"Friedl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2023.115107_bib54","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.bmc.2019.03.033","article-title":"Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo","volume":"27","author":"Zeng","year":"2019","journal-title":"Bioorg. Med Chem."},{"issue":"4","key":"10.1016\/j.biopha.2023.115107_bib55","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1470-2045(04)01431-7","article-title":"Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters","volume":"5","author":"Entschladen","year":"2004","journal-title":"Lancet Oncol."},{"issue":"13","key":"10.1016\/j.biopha.2023.115107_bib56","first-page":"1388","article-title":"Effect of Cepharanthine on migration and invasion of osteosarcoma MG-63 cells in vitro","volume":"25","author":"Ma","year":"2016","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.115107_bib57","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1080\/13880209.2017.1328446","article-title":"Determination of cepharanthine in rat plasma by LC-MS\/MS and its application to a pharmacokinetic study","volume":"55","author":"Deng","year":"2017","journal-title":"Pharm. Biol."},{"issue":"03","key":"10.1016\/j.biopha.2023.115107_bib58","first-page":"83","article-title":"Comparison of the dissolution of the cepharanthine tablets and cepharanthine dropping pills","volume":"30","author":"Wang","year":"2009","journal-title":"J. Jinggangshan Univ. (Sci. Technol. )"},{"issue":"08","key":"10.1016\/j.biopha.2023.115107_bib59","first-page":"1845","article-title":"Optimization of cepharanthine hydroxypropyl-\u03b2-cyclodextrin microspheres preparation process by response surface methodology","volume":"51","author":"Fei","year":"2022","journal-title":"Contemp. Chem. Ind."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223008983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223008983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:38:44Z","timestamp":1777880324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223008983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":59,"alternative-id":["S0753332223008983"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115107","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mechanistic updated overview on Cepharanthine as potential anticancer agent","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115107"}}